LH及其受体的药物基因组学:我们是否准备好临床实践?
Alessandro Conforti1, Raffaella Di Girolamo2, Maurizio Guida3
1Department of Neuroscience, Reproductive Science and Odontostomatology, University of Naples Federico II, Via Sergio Pansini, 5, Napoli, 80131, Italy. alessandro.conforti@unina.it.
化激素 (LH) 和它的受体是生殖和药物治疗的关键,如受控卵巢刺激 (COS). 了解遗传变异可以个性化COS,以获得更好的结果.
科学领域:
- 生殖内分泌学 生殖内分泌学
- 药物遗传学 药物遗传学
背景情况:
- 化激素 (LH) 对于生殖功能至关重要,通过其受体作用于生殖腺.
- 在受控卵巢刺激 (COS) 中,LH用于治疗,以支持卵泡发育.
研究的目的:
- 审查LH及其受体的分子通路和体内作用.
- 探索LH及其受体中的遗传变异对生殖过程和临床结果的影响.
- 讨论药物遗传学对个性化COS治疗的影响.
主要方法:
- 对LH及其受体进行的体外和体内研究的综述.
- 在LH和LH/胆激素 (hCG) 受体中的遗传变异 (多态) 的分析.
- 从辅助生殖技术 (ART) 治疗中检查临床数据.
主要成果:
- 在LH信号传递过程中涉及复杂的mitogenic,anti-apoptotic和steroidogenic路径.
- 在LH及其受体中的遗传变异可以影响卵泡发育,并与不孕症和PCOS有关.
- 有限的临床研究存在,但表明在COS中药基因组学方法的潜力.
结论:
- 对COS的药物遗传学方法对于优化治疗和最大限度地减少不良事件是相关的.
- 需要进一步的临床研究,以充分阐明遗传多态性在LH作用和COS疗效中的作用.
- 基于药物基因组学的个性化医疗策略有望改善ART的结果.
更多相关视频
05:53Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
Published on: June 21, 2018
08:46Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
相关概念视频
Desensitization and Tachyphylaxis
Analysis of Population Pharmacokinetic Data
Drug Discovery: Overview
Preclinical Development: Overview
Drug-Receptor Interactions
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Pharmacodynamics: Overview and Principles
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or...
